Safety assessment on comedogenicity of dermatological products containing d-alpha tocopheryl acetate in Asian subjects: A double-blind randomized controlled trial

Contemporary Clinical Trials Communications - Tập 23 - Trang 100834 - 2021
Neti Waranuch1,2, Sutthinee Wisutthathum2, Supaporn Tuanthai2, Pichet Kittikun2, Francois Grandmottet3, Francine Tay4, Jarupa Viyoch1,5
1Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, 65000, Thailand
2Cosmetics and Natural Products Research Center, Faculty of Pharmaceutical Sciences Naresuan University, Phitsanulok, 65000, Thailand
3Department of Biochemistry, Faculty of Medical Science, Naresuan University, Thailand
4Blackmores Institute, 20 Jubilee Avenue, Warriewood, NSW, 2102, Australia
5Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok 65000, Thailand

Tài liệu tham khảo

Kligman, 1972, Acne cosmetica, Arch. Dermatol., 106, 843, 10.1001/archderm.1972.01620150029011 Fulton, 1984, Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear, J. Am. Acad. Dermatol., 10, 96, 10.1016/S0190-9622(84)80050-X Draelos, 2006, A re-evaluation of the comedogenicity concept, J. Am. Acad. Dermatol., 54, 507, 10.1016/j.jaad.2005.11.1058 Lee, 2015, Isopropyl myristate and cocoa butter are not appropriate positive controls for comedogenicity assay in asian subjects, J Cosmo Trichol, 2, 2 Keen, 2016, Vitamin E in dermatology, Indian dermatology online journal, 7, 311, 10.4103/2229-5178.185494 Maia Campos, 2019, Use of advanced imaging techniques for the characterization of oily skin, Front. Physiol., 10, 254, 10.3389/fphys.2019.00254 Baek, 2016, Analysis of comedone, sebum and porphyrin on the face and body for comedogenicity assay, Skin Res. Technol., 22, 164, 10.1111/srt.12244 Thiboutot, 2000, The role of follicular hyperkeratinization in acne, J. Dermatol. Treat., 11, 5, 10.1080/095466300750163645 Thiboutot, 2013, Acne vulgaris and the epidermal barrier: is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier?, J. Clin. Aesthet. Dermatol., 6, 18 Tucker, 1986, Development of an objective comedogenicity assay, Arch. Dermatol., 122, 660, 10.1001/archderm.1986.01660180066016 Bowe, 2010, Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles, Lipids Health Dis., 9, 1, 10.1186/1476-511X-9-141 Chularojanamontri, 2014, Moisturizers for acne: what are their constituents?, J. Cli.n Aesthet. Dermatol., 7, 36 Cheng, 2010, Moisturizing and anti‐sebum secretion effects of cosmetic application on human facial skin, Int. J. Cosmet. Sci., 32, 10.1111/j.1468-2494.2009.00533_2.x